Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$623M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$615M |
| 3 |
IBM
IBM
|
+$448M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$368M |
| 5 |
Wells Fargo
WFC
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$791M |
| 2 |
EMC CORPORATION
EMC
|
+$736M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$501M |
| 4 |
Mondelez International
MDLZ
|
+$492M |
| 5 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$391M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.13% |
| 2 | Technology | 9.71% |
| 3 | Financials | 8.96% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6201
DELISTED
PNC Financial Services Group Inc
PNC.WS
| $2K | ﹤0.01% |
87
| – | – |
2014 Q1
10 quarters
|
|
|
PWX
6202
DELISTED
Providence & Worcester Railroad Company
PWX
| $2K | ﹤0.01% |
79
| – | – |
2013 Q4
11 quarters
|
|
|
GLDC
6203
DELISTED
GOLDEN ENTERPRISES
GLDC
| $2K | ﹤0.01% |
+167
| New | +$1.86K |
2016 Q3
0 quarters
|
|
|
PGM
6204
DELISTED
iPath Bloomberg Platinum Subindex Total Return ETN due June 24, 2038
PGM
| $2K | ﹤0.01% |
+100
| New | +$2.3K |
2016 Q3
0 quarters
|
|
6205
DELISTED
Global X Brazil Mid Cap ETF
BRAZ
| $2K | ﹤0.01% |
200
| – | – |
2013 Q4
11 quarters
|
|
6206
Aethlon Medical
AEMD
$4.17M
| – | – |
0
| – | – |
2015 Q3
4 quarters
|
|
6207
Digital Turbine
APPS
$1.29B
| $1K | ﹤0.01% |
1,360
-15,849
| -92% | -$18.4K |
2014 Q1
10 quarters
|
|
6208
American Realty Investors
ARL
$311M
| $1K | ﹤0.01% |
174
-9
| -5% | -$58 |
2015 Q3
4 quarters
|
|
6209
Barnwell Industries
BRN
$13.1M
| $1K | ﹤0.01% |
432
| – | – |
2015 Q3
4 quarters
|
|
6210
Broadway Financial
BYFC
$108M
| $1K | ﹤0.01% |
41
| – | – |
2013 Q4
11 quarters
|
|
6211
DELISTED
CASI Pharmaceuticals
CASI
| $1K | ﹤0.01% |
104
+2
| +2% | +$22 |
2014 Q3
8 quarters
|
|
6212
eGain
EGAN
$139M
| $1K | ﹤0.01% |
400
| – | – |
2016 Q1
2 quarters
|
|
6213
Enlivex Ltd
ENLV
$5.04M
| $1K | ﹤0.01% |
1
| – | – |
2016 Q1
2 quarters
|
|
6214
Euroseas
ESEA
$502M
| $1K | ﹤0.01% |
84
| – | – |
2013 Q4
11 quarters
|
|
6215
DELISTED
Evoke Pharma
EVOK
| $1K | ﹤0.01% |
+3
| New | +$1.37K |
2016 Q3
0 quarters
|
|
6216
Fate Therapeutics
FATE
$255M
| $1K | ﹤0.01% |
169
-861
| -84% | -$2.09K |
2015 Q2
5 quarters
|
|
6217
Flexible Solutions
FSI
$78.1M
| $1K | ﹤0.01% |
290
-24,733
| -99% | -$44.9K |
2016 Q2
1 quarter
|
|
6218
New Concept Energy
GBR
$3.59M
| $1K | ﹤0.01% |
+200
| New | +$703 |
2016 Q3
0 quarters
|
|
6219
Globus Maritime Ltd
GLBS
$73.2M
| – | – |
0
| – | – |
2015 Q4
3 quarters
|
|
6220
DELISTED
Glen Burnie Bancorp
GLBZ
| $1K | ﹤0.01% |
67
-1,133
| -94% | -$11.9K |
2013 Q4
11 quarters
|
|
6221
Hudson Technologies
HDSN
$215M
| $1K | ﹤0.01% |
+200
| New | +$1.06K |
2016 Q3
0 quarters
|
|
6222
Abundia Global Impact Group
AGIG
$40.6M
| $1K | ﹤0.01% |
56
| – | – |
2013 Q4
11 quarters
|
|
6223
DELISTED
KalVista Pharmaceuticals
KALV
| $1K | ﹤0.01% |
201
-686
| -77% | -$5.17K |
2015 Q2
5 quarters
|
|
6224
Kiora Pharmaceuticals
KPRX
$11.3M
| – | – |
0
| – | – |
2016 Q3
0 quarters
|
|
6225
LGL Group
LGL
$83.2M
| $1K | ﹤0.01% |
530
| – | – |
2013 Q4
11 quarters
|
|
Similar funds
Morgan Stanley's Q3 2016 Portfolio in Review
As of Q3 2016, Morgan Stanley held 6,800 positions worth $293B, up 5.8% from $277B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Morgan Stanley's Q3 2016 filing shows 189 new, 3,183 increased, 2,670 reduced and 222 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $791M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 2,617,803 shares worth $85.8M.
- Morgan Stanley added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2016, an estimated $623M increase.
- Morgan Stanley's biggest Q3 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $791M.
- Morgan Stanley fully exited EMC CORPORATION in Q3 2016, selling an estimated $736M.
- Morgan Stanley's ten largest holdings make up 13% of its $293B portfolio in Q3 2016.
- Morgan Stanley opened 189 new positions and closed 222 in Q3 2016.
- Morgan Stanley's portfolio value rose 5.8% quarter-over-quarter to $293B.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.